Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)
A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Jazz around $16 making me Dizzy - favors the shorts from here
Recs
Looming FDA approvial
Recs
Garbage. Garbage. Garbage!!! See what happens if they fail a drug trial!
Recs
NDA plus buyout potential plus improved bottom line. Looks good as a spec.
Recs
JAZZ has a too high valuation compared to its sales potential. It is also one of the most loss making companies. Its stock price may be more than halved.
Recs
Insiders /Phase 111
Recs
Hm...............insider bought 1.5 million shares.
Recs
Great stock..new drug offering!!!
Recs
this was too quick of a run. Especially only after a trail run.
Recs
Steep run up recently looks good for red thumb and their cash position is 1/3 of what it was 2 quarters ago
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 21 - 30 of 30 : « Previous 1 2